Journal of Medicine and Philosophy 32 (4):339 – 358 (2007)
AbstractResearch protocols must have a reasonable balance of risks and anticipated benefits to be ethically and legally acceptable. This article explores three characteristics of research on reproductive genetic technologies that complicate the assessment of the risk-benefit ratio for such research. First, a number of different people may be affected by a research protocol, raising the question of who should be considered to be the subject of reproductive genetic research. Second, such research could involve a wide range of possible harms and benefits, making the evaluation and comparison of those harms and benefits a challenging task. Finally, the risk-benefit ratio for this type of research is difficult to estimate because such research can have unpredictable, long-term implications. The article aims to facilitate the assessment of risk-benefit ratios in research on reproductive genetic technologies by proposing and defending some guidelines for dealing with each of these complicating factors.
Similar books and articles
Solidaroty and Equity : New Ethical Frameworks for Genetic Databases.Ruth Chadwick & Kåre Berg - 2001 - .
Participants' Perceptions of Research Benefits in an African Genetic Epidemiology Study.John Appiah-Poku, Sam Newton & Nancy Kass - 2011 - Developing World Bioethics 11 (3):128-135.
When Are Research Risks Reasonable in Relation to Anticipated Benefits?Charles Weijer & Paul B. Miller - unknown
Benefits to Research Subjects in International Trials: Do They Reduce Exploitation or Increase Undue Inducement?Angela Ballantyne - 2008 - Developing World Bioethics 8 (3):178-191.
Use or Refuse Reproductive Genetic Technologies: Which Would a 'Good Parent' Do?Janet Malek - 2013 - Bioethics 27 (2):59-64.
Undesirable Implications of Disclosing Individual Genetic Results to Research Participants.Leslie Meltzer Henry - unknown
Knowledge, Bodies, and Values: Reproductive Technologies and Their Scientific Context.Helen E. Longino - 1992 - Inquiry: An Interdisciplinary Journal of Philosophy 35 (3-4):323 – 340.
Refuting the Net Risks Test: A Response to Wendler and Miller's "Assessing Research Risks Systematically".Charles Weijer & Paul B. Miller - 2007 - Journal of Medical Ethics 33 (8):487-490.
Added to PP
Historical graph of downloads
Citations of this work
Informed Decision Making About Predictive DNA Tests: Arguments for More Public Visibility of Personal Deliberations About the Good Life. [REVIEW]Marianne Boenink & Simone van der Burg - 2010 - Medicine, Health Care and Philosophy 13 (2):127-138.
References found in this work
No references found.